Takeda Pharmaceutical Company Limited
SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF

Last updated:

Abstract:

Provided is a substituted piperidine compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): ##STR00001## wherein each symbol is as described in the DESCRIPTION, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as a prophylactic or therapeutic agent for narcolepsy.

Status:
Application
Type:

Utility

Filling date:

21 Jan 2021

Issue date:

17 Mar 2022